Navigation Links
First-of-its-Kind Study Released at the SGNA 36th Annual Conference Reveals Inconsistency in GI Endoscope Reprocessing
Date:5/18/2009

ST. LOUIS, May 18 /PRNewswire/ -- Preliminary results from the first-of-its-kind Clinical Evaluation and Assessment of Endoscope Reprocessing (CLEANR) study was released today at the Society of Gastroenterology Nurses and Associates, Inc. (SGNA) 36th Annual Conference in St. Louis, MO. The study indicated that while there are written endoscope reprocessing guidelines in place at the sites who participated in the study, significant variation in manual reprocessing takes place, leading to challenges with achieving consistent gastrointestinal (GI) endoscope reprocessing practices. The observational study was led by Cori L. Ofstead, MSPH, of Ofstead & Associates, Inc., a healthcare research firm, and sponsored by Advanced Sterilization Products (ASP). Other key employee-related findings included:

  • Majority of experienced workers "disliked" some of the manual reprocessing tasks;
  • 70 percent felt pressure to work quickly;
  • More than half experienced discomfort associated with reprocessing;
  • Employees indicated that using more automated systems provided increased consistency and better compliance-related documentation than manual processing.

According to Cori L. Ofstead, MSPH, lead researcher, "This study shows that institutions have adopted written GI endoscope reprocessing guidelines, yet there are clearly suboptimal practices and wide variations in adherence within and between institutions. Our findings indicate the majority of employees experience occupational health problems attributed to reprocessing, and many of them dislike tasks associated with manual cleaning. We found that automation improves consistency and employee satisfaction. In accordance with Centers for Disease Control (CDC) guidelines, every facility should reexamine its practices, and seek ways to improve occupational health and reduce infection risks for patients."

Background on Study and Additional Findings

The CLEANR Study was conducted from October 2008 through April 2009 at six U.S. sites (only five provided data in the required timeframe) including two gastroenterology centers, three multi-specialty hospitals, and one outpatient surgery center. Participating sites used a variety of reprocessing methodologies ranging from manual cleaning with brushes to automated channel irrigators and other automated systems including the ASP EVOTECH(TM) Endoscope Cleaner and Reprocessor. The EVOTECH(TM) System is the first commercially available system in the U.S. that both cleans and high-level disinfects endoscopes. It does not eliminate bedside precleaning in procedure room and no manual cleaning is required when selecting a cycle that has a wash stage.

Managers were interviewed and individuals tasked with the responsibility of cleaning endoscopes after a GI procedure were surveyed and their actions documented by an observer. Managers at every site stated that written reprocessing policies were in place. Study results indicated that GI endoscope reprocessing time varied by the individual, and its variability resulted in:

  • Majority of endoscopes using traditional reprocessing techniques were not reprocessed in accordance with existing reprocessing guidelines.
  • Inconsistency in brushing, detergent flush, rinsing, alcohol flushes and forced-air drying times:
    • Brush times ranged from 10 seconds to 2:30 minutes.
    • Detergent flush times ranged from 18 seconds to 2:45 minutes.
    • Sites with consistent flush times were using an automated channel irrigator.
    • Rinsing times ranged from 76 seconds to 3:20 minutes.
    • Alcohol flushes were only documented in 39.5 percent of instances.
    • Forced air was used in 81.5 percent of instances.

"ASP realizes that ensuring proper GI endoscope reprocessing is a complex and challenging task, and not all facilities have these issues," said Barbara Trattler, Director, Clinical Education at ASP. "ASP will continue to partner with our customers and industry to increase awareness of best practices in reprocessing. We are also dedicated to developing new technology solutions such as the EVOTECH(TM) Endoscope Cleaner and Reprocessor - the first commercially available system to eliminate the labor-intensive manual cleaning of endoscopes - to help improve compliance and increase employee satisfaction."

About Ofstead & Associates, Inc.

Ofstead & Associates is an independent research organization that gathers, analyzes, interprets, and summarizes evidence-based scientific and clinical information for clinicians and healthcare industry executives. Since 1996, Ofstead has focused exclusively on providing customized research services for clients in the medical field. Ofstead is committed to fostering excellence in healthcare by combining tailored research services and medical insights with practical approaches for developing high-quality output.

About ASP

Advanced Sterilization Products (ASP), division of Ethicon, Inc., a Johnson & Johnson company, has a long track record of designing and delivering innovative infection prevention solutions. Our pioneering technology, global distribution, and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day, for thousands of medical facilities around the world. This in turn enables our customers to focus on what they do best - preventing infection and saving lives. www.evotechecr.com


'/>"/>
SOURCE Advanced Sterilization Products
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. First-of-Its-Kind Program Aims to Reduce Primary Barrier to Breastfeeding for Hourly and Lower-Wage Working Mothers
2. AltaMed Opens First-of-its-Kind Health Care Center in the Nation
3. Ortho-McNeil initiates first-of-its-kind skin infection registry
4. Baker Energy and Huber Receive First-of-its-Kind Award from Wyoming Department of Environmental Quality
5. Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
6. Coalition to Prevent Deep-Vein Thrombosis (DVT) Turns Awareness Into Action as it Declares First-Of-Its-Kind National DVT Screening Day
7. First-of-Its-Kind National Online Survey Uncovers Obstacles to Comprehensive Healthcare for People With Schizophrenia
8. First-of-Its-Kind National Survey Uncovers Obstacles to Comprehensive Healthcare for People With Schizophrenia
9. Benefitfocus(R) Unwraps First-of-Its-Kind Healthcare Media Studio
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Study sees transient heart dysfunction in some long-distance runners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
(Date:3/24/2017)... ... 2017 , ... “Finding Christ Through Social Media: Year One ... the writer’s path toward true communion with God. “Finding Christ Through Social Media: ... creation of published author Lea Michelle Johnson, a follower of Christ, wife and ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of ... people of God in congregations across the United States. “The Communion of ... in 1964 who has served congregations in seven states throughout his long career ...
(Date:3/23/2017)... ... 23, 2017 , ... A recent report from the National Council on Teacher ... NCTQ report suggests, based on a review of GPA and SAT/ACT requirements at 221 ... the U.S. It argues that this higher bar should be set by states, by ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) ... Road in Building 2. The clinic is the group’s second in New Braunfels and ... the company’s second New Braunfels location brings things full circle for the group, “It’s ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and ... 2015 through 2022. Also, a six-year historic analysis is provided for these ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly ... announced plans to invest $850 million in its ... facilities across its U.S. enterprise, including research laboratories, ... investments are being driven by demand for Lilly ... potential medicines in development targeting cancer, pain, diabetes ...
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, ... advanced medical technology for non-invasive surgery, announced today ... System for treatment of uterine fibroids throughout the ... had received approval from the US Food and ... the Mirabilis System in the United States.  The ...
Breaking Medicine Technology: